Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis
Teresa Cabaleiro, Rocío Prieto‐Pérez, Raquel Navarro, et al.
The Pharmacogenomics Journal (2015) Vol. 16, Iss. 4, pp. 336-340
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon
Alessio Mylonas, Curdin Conrad
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 127
Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders
Simone Garcovich, Clara De Simone, Giovanni Genovese, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 79
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options
Carlo Alberto Maronese, Mario Valenti, Chiara Moltrasio, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 11, pp. 2364-2376
Closed Access | Times Cited: 10
Genetic influences on susceptibility to rheumatoid arthritis in African-Americans
Vincent A. Laufer, Hemant K. Tiwari, Richard J. Reynolds, et al.
Human Molecular Genetics (2018) Vol. 28, Iss. 5, pp. 858-874
Open Access | Times Cited: 70
Histone modifications associated with biological drug response in moderate‐to‐severe psoriasis
María C. Ovejero‐Benito, Alejandra Reolid, Patricia Sánchez‐Jiménez, et al.
Experimental Dermatology (2018) Vol. 27, Iss. 12, pp. 1361-1371
Closed Access | Times Cited: 66
Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report
Artsiom Klimko, Andrei Ovidiu Olteanu, Ioana Ţieranu, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 106-106
Open Access | Times Cited: 6
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease
Pierluigi Puca, I. Capobianco, Gaetano Coppola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2789-2789
Open Access | Times Cited: 6
Risk Factors for Psoriasis Flares: A Narrative Review
Luca Potestio, Giuseppe Lauletta, Nello Tommasino, et al.
Psoriasis Targets and Therapy (2024) Vol. Volume 14, pp. 39-50
Open Access | Times Cited: 6
Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis
Valerio Caputo, Claudia Strafella, Terenzio Cosio, et al.
Genes (2021) Vol. 12, Iss. 9, pp. 1398-1398
Open Access | Times Cited: 40
Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis
Cristina Membrive-Jiménez, Cristina Pérez-Ramírez, Almudena Sánchez Martín, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 4, pp. 293-293
Open Access | Times Cited: 33
Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine
Emilio Berná-Rico, Javier Perez-Bootello, Carlota Abbad‐Jaime de Aragón, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9850-9850
Open Access | Times Cited: 15
Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review
Ching-Ya Wang, Chuang‐Wei Wang, Chun‐Bing Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7329-7329
Open Access | Times Cited: 14
Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors
Martina Morelli, Maria Luigia Carbone, Giovanni Luca Scaglione, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management
J.M. Carrascosa, Elena Del-Alcazar
Expert Review of Clinical Immunology (2018) Vol. 14, Iss. 4, pp. 259-273
Closed Access | Times Cited: 40
Reacciones paradójicas de los tratamientos biológicos utilizados en psoriasis: revisión de la literatura
M. Munera‐Campos, F. Ballescà, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2018) Vol. 109, Iss. 9, pp. 791-800
Closed Access | Times Cited: 40
Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers
Agostino Bucalo, Federica Rega, Arianna Zangrilli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7873-7873
Open Access | Times Cited: 30
Childhood guttate psoriasis: an updated review
Alexander K. C. Leung, Benjamin Barankin, Joseph M. Lam, et al.
Drugs in Context (2023) Vol. 12, pp. 1-20
Open Access | Times Cited: 10
Paradoxical Reactions to Biologic Therapy in Psoriasis: A Review of the Literature
M. Munera‐Campos, F. Ballescà, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2018) Vol. 109, Iss. 9, pp. 791-800
Open Access | Times Cited: 31
Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development
Luca Fania, Martina Morelli, Claudia Scarponi, et al.
The Journal of Pathology Clinical Research (2019) Vol. 6, Iss. 1, pp. 55-68
Open Access | Times Cited: 29
Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?
Jiawei Lu, Yan Lü
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100211-100211
Open Access | Times Cited: 9
Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases
Soheil Tavakolpour, Mohammad Darvishi, Mojtaba Ghasemiadl
Clinical Genetics (2017) Vol. 93, Iss. 3, pp. 481-497
Open Access | Times Cited: 28
Paradoxical skin lesions induced by anti-TNF-α agents in SAPHO syndrome
Chen Li, Xia Wu, Yihan Cao, et al.
Clinical Rheumatology (2018) Vol. 38, Iss. 1, pp. 53-61
Closed Access | Times Cited: 24
Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy
Αναστάσιος Καραμανάκος, Theognosia Vergou, Stylianos Panopoulos, et al.
European Journal of Dermatology (2021) Vol. 31, Iss. 3, pp. 307-317
Closed Access | Times Cited: 19
Pharmacogenetics and pharmacogenomics in psoriasis treatment: current challenges and future prospects
Alison Margaret Semple Sutherland, Rebecca Power, Proton Rahman, et al.
Expert Opinion on Drug Metabolism & Toxicology (2016) Vol. 12, Iss. 8, pp. 923-935
Closed Access | Times Cited: 20
Association between several immune response‐related genes and the effectiveness of biological treatments in patients with moderate‐to‐severe psoriasis
Alba Loras, Marta Gil‐Barrachina, Bárbara Hernando, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top